Nilo Therapeutics
Recent Finacing
Series A
Recent Raise
$101M
Nilo Therapeutics is a NYC-based biotechnology company developing neuro-immunology drugs that harness neural circuits to restore immune homeostasis in autoimmune and inflammatory diseases.
Highlights
Focus Areas
Biotechnology
Health Care
Therapeutics
Wellness
Recent Investors
Financials
$101M
Total Raised
1
Funding round
5
Investors